{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:50:50Z","timestamp":1786985450967,"version":"build-2736575974"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006785","name":"Google","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006785","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biophysical Chemistry"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.bpc.2020.106478","type":"journal-article","created":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T17:05:28Z","timestamp":1600794328000},"page":"106478","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["1,2,4 triazolo[1,5-a] pyrimidin-7-ones as novel SARS-CoV-2 Main protease inhibitors: In silico screening and molecular dynamics simulation of potential COVID-19 drug candidates"],"prefix":"10.1016","volume":"267","author":[{"given":"Kuppuswamy","family":"Kavitha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subramaniam","family":"Sivakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balasubramanian","family":"Ramesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpc.2020.106478_bb0005","article-title":"Global economy could shrink by almost 1% in 2020 due to COVID-19 pandemic: United Nations","author":"UN-DESA","year":"2020","journal-title":"Econ. Time"},{"key":"10.1016\/j.bpc.2020.106478_bb0010","first-page":"1","article-title":"In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel","author":"Gupta","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bpc.2020.106478_bb0015","first-page":"1","article-title":"SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an in silico perspective","author":"Elfiky","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bpc.2020.106478_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07391102.2020.1762743","article-title":"Stilbene-based natural compounds as promising drug candidates against COVID-19","author":"Wahedi","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bpc.2020.106478_bb0025","doi-asserted-by":"crossref","first-page":"105949","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","author":"Gautret","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.bpc.2020.106478_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.medmal.2020.03.006","article-title":"No Evidence of Rapid Antiviral Clearance or Clinical Benefit with the Combination of Hydroxychloroquine and Azithromycin in Patients with Severe COVID-19 Infection","author":"Molina","year":"2020","journal-title":"M\u00e9decine Mal. Infect."},{"key":"10.1016\/j.bpc.2020.106478_bb0035","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Manli","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.bpc.2020.106478_bb0040","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13063-017-2427-0","article-title":"Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-\u03b21b (MIRACLE trial): study protocol for a randomized controlled trial","volume":"19","author":"Arabi","year":"2018","journal-title":"Trials"},{"key":"10.1016\/j.bpc.2020.106478_bb0045","series-title":"Virtual screening of approved clinic drugs with main protease (3CL pro) reveals potential inhibitory effects on SARS-CoV-2","author":"Qiang","year":"2020"},{"key":"10.1016\/j.bpc.2020.106478_bb0050","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.bbrc.2004.04.083","article-title":"HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus","volume":"318","author":"Yamamoto","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bpc.2020.106478_bb0055","article-title":"Nelfinavir Is Active Against SARS-CoV-2 in Vero E6 Cells","author":"Zhijian","year":"2020","journal-title":"ChemRxiv. Prepr."},{"key":"10.1016\/j.bpc.2020.106478_bb0060","first-page":"1","article-title":"A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin","author":"Hasan","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bpc.2020.106478_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07391102.2020.1758788","article-title":"Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment","author":"Boopathi","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bpc.2020.106478_bb0070","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1128\/JVI.02114-07","article-title":"Structures of two coronavirus Main proteases: implications for substrate binding and antiviral drug design","volume":"82","author":"Xue","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.bpc.2020.106478_bb0075","first-page":"1","article-title":"Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19","author":"Muralidharan","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bpc.2020.106478_bb0080","first-page":"1","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors","volume":"3405","author":"Zhang","year":"2020","journal-title":"Science."},{"key":"10.1016\/j.bpc.2020.106478_bb0085","doi-asserted-by":"crossref","first-page":"127377","DOI":"10.1016\/j.bmcl.2020.127377","article-title":"The SARS-CoV-2 main protease as drug target","volume":"30","author":"Ullrich","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bpc.2020.106478_bb0090","first-page":"115","article-title":"Quaternary structure of the SARS coronavirus main protease","author":"Chang","year":"2009","journal-title":"Mol. Biol. SARS-Coronavirus."},{"key":"10.1016\/j.bpc.2020.106478_bb0095","first-page":"1","article-title":"Pharmacoinformatics and molecular dynamics simulation studies reveal potential covalent and FDA-approved inhibitors of SARS-CoV-2 main protease 3CLpro","author":"Alamri","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bpc.2020.106478_bb0100","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10930-020-09884-2","article-title":"Covalent versus non-covalent enzyme inhibition: which route should we take? A justification of the good and bad from molecular modelling perspective","volume":"39","author":"Aljoundi","year":"2020","journal-title":"Protein J."},{"key":"10.1016\/j.bpc.2020.106478_bb0105","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The Protein Data Bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bpc.2020.106478_bb0110","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1093\/bioinformatics\/btq572","article-title":"Pre-calculated protein structure alignments at the RCSB PDB website","volume":"26","author":"Prlic","year":"2010","journal-title":"Bioinformatics."},{"key":"10.1016\/j.bpc.2020.106478_bb0115","first-page":"17","article-title":"The crystal structure of COVID-19 main protease in complex with an inhibitor N3","author":"Liu","year":"2020","journal-title":"PDB Release."},{"key":"10.1016\/j.bpc.2020.106478_bb0120","first-page":"1","article-title":"Rapid Identification of Potential Inhibitors of SARS-CoV-2 Main Protease by Deep Docking of 1.3 Billion Compounds","volume":"2000028","author":"Ton","year":"2020","journal-title":"Mol. Inform."},{"key":"10.1016\/j.bpc.2020.106478_bb0125","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1021\/acs.jcim.5b00559","article-title":"ZINC 15 \u2013 ligand discovery for everyone","volume":"55","author":"Sterling","year":"2015","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bpc.2020.106478_bb0130","doi-asserted-by":"crossref","first-page":"W636","DOI":"10.1093\/nar\/gkz268","article-title":"The EMBL-EBI search and sequence analysis tools APIs in 2019","volume":"47","author":"Madeira","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bpc.2020.106478_bb0135","first-page":"406","article-title":"The neighbor-joining method-a new method for reconstructing phylogenetic trees","volume":"4","author":"Saitou","year":"1987","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.bpc.2020.106478_bb0140","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/molbev\/msy096","article-title":"MEGA X: Molecular evolutionary genetics analysis across computing platforms","volume":"35","author":"Kumar","year":"2018","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.bpc.2020.106478_bb0145","first-page":"783","article-title":"Confidence limits on phylogenies: An approach using the bootstrap","volume":"39","author":"Felsenstein","year":"1985","journal-title":"Evolution (N. Y)"},{"key":"10.1016\/j.bpc.2020.106478_bb0150","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/B978-1-4832-2734-4.50017-6","article-title":"Evolutionary divergence and convergence in proteins","author":"Zuckerkandl","year":"1965","journal-title":"Evol. Genes Proteins."},{"key":"10.1016\/j.bpc.2020.106478_bb0155","doi-asserted-by":"crossref","first-page":"W320","DOI":"10.1093\/nar\/gku316","article-title":"Deciphering key features in protein structures with the new ENDscript server","volume":"42","author":"Robert","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bpc.2020.106478_bb0160","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera--a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bpc.2020.106478_bb0165","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1002\/elps.1150181505","article-title":"SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling","volume":"18","author":"Guex","year":"1997","journal-title":"Electrophoresis."},{"key":"10.1016\/j.bpc.2020.106478_bb0170","doi-asserted-by":"crossref","first-page":"W363","DOI":"10.1093\/nar\/gky473","article-title":"CASTp 3.0: computed atlas of surface topography of proteins","volume":"46","author":"Tian","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bpc.2020.106478_bb0175","series-title":"ChemAxon, MarvinView 20.9.0","year":"2020"},{"key":"10.1016\/j.bpc.2020.106478_bb0180","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open babel: an open chemical toolbox","volume":"3","author":"O\u2019Boyle","year":"2011","journal-title":"J. Cheminform."},{"key":"10.1016\/j.bpc.2020.106478_bb0185","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bpc.2020.106478_bb0190","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-2269-7_19","article-title":"Small-molecule library screening by docking with PyRx","volume":"1263","author":"Dallakyan","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bpc.2020.106478_bb0195","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jsb.2011.09.006","article-title":"UCSF Chimera, MODELLER, and IMP: an integrated modeling system","volume":"179","author":"Yang","year":"2012","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.bpc.2020.106478_bb0200","doi-asserted-by":"crossref","first-page":"64","DOI":"10.5582\/bst.2020.01030","article-title":"Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment","volume":"14","author":"Wang","year":"2020","journal-title":"Biosci. Trends."},{"key":"10.1016\/j.bpc.2020.106478_bb0205","first-page":"1","article-title":"Structural basis of SARS-CoV-2 3CL pro and anti-COVID-19 drug discovery from medicinal plants","author":"Tahir","year":"2020","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.bpc.2020.106478_bb0210","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bpc.2020.106478_bb0215","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1021\/ci300367a","article-title":"admetSAR: A comprehensive source and free tool for assessment of chemical ADMET properties","volume":"52","author":"Cheng","year":"2012","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bpc.2020.106478_bb0220","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.micres.2014.06.002","article-title":"Phenazine-1-carboxylic acid mediated anti-oomycete activity of the endophytic Alcaligenes sp. EIL-2 against Phytophthora meadii","volume":"170","author":"Abraham","year":"2015","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.bpc.2020.106478_bb0225","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1107\/S0907444904011679","article-title":"PRODRG: a tool for high-throughput crystallography of protein-ligand complexes","volume":"60","author":"Sch\u00fcttelkopf","year":"2004","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"10.1016\/j.bpc.2020.106478_bb0230","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1021\/ct700200b","article-title":"P-LINCS: a parallel Linear constraint solver for molecular simulation","volume":"4","author":"Hess","year":"2008","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.bpc.2020.106478_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."},{"key":"10.1016\/j.bpc.2020.106478_bb0240","doi-asserted-by":"crossref","first-page":"W443","DOI":"10.1093\/nar\/gkv315","article-title":"PLIP: fully automated protein\u2013ligand interaction profiler","volume":"43","author":"Salentin","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bpc.2020.106478_bb0245","doi-asserted-by":"crossref","first-page":"10037","DOI":"10.1073\/pnas.181342398","article-title":"Electrostatics of nanosystems: application to microtubules and the ribosome","volume":"98","author":"Baker","year":"2001","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bpc.2020.106478_bb0250","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1021\/ci500020m","article-title":"g_mmpbsa\u2014A GROMACS Tool for High-Throughput MM-PBSA Calculations","volume":"54","author":"Kumari","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bpc.2020.106478_bb0260","first-page":"1","article-title":"Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach","author":"Khan","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bpc.2020.106478_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07391102.2020.1761883","article-title":"A molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2","author":"Islam","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bpc.2020.106478_bb0270","first-page":"1","article-title":"In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain)","author":"Sarma","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bpc.2020.106478_bb0275","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bpc.2020.106478_bb0280","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1021\/cc9800071","article-title":"A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases","volume":"1","author":"Ghose","year":"1999","journal-title":"J. Comb. Chem."},{"key":"10.1016\/j.bpc.2020.106478_bb0285","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the Oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bpc.2020.106478_bb0290","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1021\/jm000292e","article-title":"Prediction of drug absorption using multivariate statistics","volume":"43","author":"Egan","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bpc.2020.106478_bb0295","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1021\/jm015507e","article-title":"Simple selection criteria for drug-like chemical matter","volume":"44","author":"Muegge","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bpc.2020.106478_bb0300","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1021\/jm901137j","article-title":"New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays","volume":"53","author":"Baell","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bpc.2020.106478_bb0305","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/cmdc.200700139","article-title":"Lessons learnt from assembling screening libraries for drug discovery for neglected diseases","volume":"3","author":"Brenk","year":"2008","journal-title":"ChemMedChem."},{"key":"10.1016\/j.bpc.2020.106478_bb0310","first-page":"1","article-title":"Drug repurposing for coronavirus (COVID-19): in silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes","author":"Elmezayen","year":"2020","journal-title":"J. Biomol. Struct. Dyn."}],"container-title":["Biophysical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301462220301861?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301462220301861?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T07:55:16Z","timestamp":1759564516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301462220301861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":61,"alternative-id":["S0301462220301861"],"URL":"https:\/\/doi.org\/10.1016\/j.bpc.2020.106478","relation":{},"ISSN":["0301-4622"],"issn-type":[{"value":"0301-4622","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"1,2,4 triazolo[1,5-a] pyrimidin-7-ones as novel SARS-CoV-2 Main protease inhibitors: In silico screening and molecular dynamics simulation of potential COVID-19 drug candidates","name":"articletitle","label":"Article Title"},{"value":"Biophysical Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpc.2020.106478","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106478"}}